This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1534734608324124v1 7/4/198    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rattan, R. Articles by Nayak, D. Search for Related Content PubMed PubMed Citation Articles by Rattan, R. Articles by Nayak, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetic Foot Hazardous Substances DB MALONALDEHYDE Social Bookmarking                         What's this?

High Levels of Plasma Malondialdehyde, Protein Carbonyl, and Fibrinogen Have Prognostic Potential to Predict Poor Outcomes in Patients With Diabetic Foot Wounds: A Preliminary Communication

^* To whom correspondence should be addressed. E-mail: rattanroma{at}yahoo.com.

	Abstract

Diabetic foot ulcer (DFU) is the leading cause of lower extremity amputation and is generally known to have poor prognosis. Oxidative stress is considered important in the pathogenesis of chronic wounds. Fibrinogen is a recognized marker in peripheral vascular disease; increasing levels predict an increased mortality and risk of amputation. The aim of this study was to evaluate if plasma malondialdehyde (MDA), protein carbonyl (PC) and fibrinogen levels can be used as prognostic markers in patients with DFU. The study design was prospective, nonrandomized, and controlled. A total of 41 DFU grade 1 and 20 DFU grade 2 patients were studied in this case–control study. Diabetic controls without foot ulcers and healthy controls were also studied. Plasma MDA, PC, and fibrinogen levels were significantly higher in patients with DFU compared with those without ulcers (P < .05) and nondiabetic controls (P < .001). These parameters increased in association with DFU grade (P < .01). Increased levels of plasma fibrinogen, MDA, and PC correlated with worsened outcomes. An augmented oxidative stress and plasma fibrinogen level >300.4 mg% (95% confidence interval, 100% sensitivity, 99.2% specificity) was correlated with a high risk of amputation in DFU.

First published on September 24, 2008, doi:10.1177/1534734608324124

The International Journal of Lower Extremity Wounds 2008;7:198.

A more recent version of this article appeared on December 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Weigelt, B. Rose, U. Poschen, D. Ziegler, G. Friese, K. Kempf, W. Koenig, S. Martin, and C. Herder Immune Mediators in Patients With Acute Diabetic Foot Syndrome Diabetes Care, August 1, 2009; 32(8): 1491 - 1496. [Abstract] [Full Text] [PDF]